After more than two decades in the drug safety industry, I have a confession: I still have a deep, personal apprehension about using the abbreviation ‘PV’ to denote Pharmacovigilance. It’s a two-letter identity crisis, and for many of us with a clinical background, it’s a source of genuine, albeit humorous, confusion. Here is the history […]